DEERLAND TO PRESENT INITIAL RESULTS FROM CLINICAL TRIAL ON DE111® PROBIOTIC AT THE ISSN SPORTS NUTRITION CONFERENCE

Deerland will share results from their latest clinical study at the International Society of Sports Nutrition (ISSN) 15th Annual Conference and Expo, which is held from June 7 to 9, 2018 in Clearwater Beach, FL. Dr. Jeremy R. Townsend of Lipscomb University in Nashville, TN will present preliminary data on Deerland’s exclusive strain of Bacillus subtilis DE111 titled “The Effect of Probiotic Supplementation on Markers of Immune and Endocrine Status in Division I Baseball Players.”

The purpose of the investigation was to study the effects of probiotic supplementation on potential immune and hormonal markers of overtraining and overreaching in team sport athletes. The double blind, placebo-controlled, randomized study involved 25 Division I male baseball athletes throughout their 12-week offseason training program. The results of this investigation showed TNF-α concentrations were significantly lower in the DE111 group. A trend for lower cortisol in the DE111 group was also observed compared to the placebo. These findings indicate that DE111 probiotic supplementation may reduce systemic low-grade inflammation.

ISSN conference participants can learn more about clinical studies like this one during the poster presentations from 12 to 2 pm on Saturday, June 9th. Learn more about Deerland’s product innovation at deerlandenzymes.com/products/.

About Deerland Enzymes and Probiotics
Deerland Enzymes & Probiotics, based in Kennesaw, Ga., specializes in customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and often proprietary solutions. In addition to customized formulations, the company offers a line of university and clinically studied branded products. Deerland provides regulatory support and also performs specialty contract manufacturing services, including bulk blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling. To contact Deerland Enzymes & Probiotics, call 800.697.8179 or email info@DeerlandEnzymes.com.

About DE111® 
DE111 is a genome sequenced and clinically tested strain of Bacillus subtilis, a probiotic spore that supports digestive and immune health. The genome sequencing confirmed the strain contained no plasmids, antibiotic resistant or deleterious genes; the human clinical studies showed the strain’s ability to control microbial populations, aid in digestion and maintain general health. DE111 has the ability to form spores that protect the microbes from harsh conditions until they enter an environment ripe for germination, such as the GI tract. Because of this spore-forming ability, DE111 remains viable under a wide temperature and pH range, making it ideal for use in supplements as well as food and beverages.

Read more at deerlandenzymes.com

Follow us on social media for the latest updates in B2B!

Image

Latest

Women's empowerment
Seizing the Narrative: The Transformative Impact of Storytelling on Women’s Empowerment
April 19, 2024

With gender equality becoming a significant global agenda, the narrative around women’s empowerment is more relevant than ever. Amid rising awareness and shifting societal norms, women are increasingly seeking avenues for self-expression and empowerment. A recent study by the Global Gender Gap Report highlights that while progress is being made, substantial efforts are still […]

Read More
V2G technology
Plug into the Future: Decoding V2G for Utility Applications
April 19, 2024

Brian Rudy from Verizon IoT and Melissa Chan of Fermata Energy explore the cutting-edge potential of vehicle-to-grid (V2G) technology at DISTRIBUTECH 2024. Their discussion highlights how this innovation transforms electric vehicles into dynamic energy storage units, capable of stabilizing the grid by storing and discharging power as needed. This technology represents a significant shift […]

Read More
zero trust architecture
Secure Grid Modernization with Zero Trust Architecture
April 19, 2024

Ray Bauer of Verizon Business engages with Del Rodriguez from Palo Alto Networks at DISTRIBUTECH 2024. Rodriguez shares insights into the significance of cybersecurity within the utility sector, particularly in light of increasing cyber threats and the convergence of IT and operational technology (OT). Bauer and Rodriguez discuss Palo Alto Networks’ initiatives to enhance […]

Read More
private wireless networks
Private Wireless Networks
April 19, 2024

Verizon host Wayne Weeks discusses the evolving utility industry with John Gaster, CEO of KSI Data Sciences at DISTRIBUTECH 2024. Together, they explore how KSI focuses on harnessing data from remote sensing devices to enhance the safety, efficiency, and cost-effectiveness of utility operations. Gaster emphasizes the significant role of AI and machine learning in […]

Read More